Analyses of mechanisms underlying drug resistance as it develops in vivo in therapy-naïve distant metastases of ER+ breast cancers cannot be assessed in organoid cultures but can now be analyzed in NSG-Pro mice. Here, ESR1 is linked to breast carcinoma.